HOME - OUR SCIENCE - INVESTIGATOR SPONSORED STUDIES Investigator Sponsored Studies Welcome to Ipsen's Investigator Sponsored Studies (ISS) Portal Ipsen supports independent research relating to disease areas of interest to Ipsen to advance research and enhance disease understanding. Investigator Sponsored Studies (ISS) investigators and/or their affiliated institutions take responsibility for the study as the Sponsor. The obligations of a sponsor-investigator include both those of a sponsor and those of an investigator. This means taking responsibility for all aspect of the study, including study: Design Regulatory approval Initiation Conduct Monitoring Reporting of safety data Analysis and publication of the results. Your ISS proposal will be reviewed by Ipsen Medical Affairs Review Board for scientific merit as well as safety, legal, ethical and budgetary considerations. Support for endorsed proposals may be provided in the form of financial support and/or study drug supply pursuant to a written agreement which requires that you – as sponsor – comply with applicable local laws, rules, guidelines and regulations. How to apply for ISS support? You are invited to submit your research proposal (outline) via VisionTracker, Ipsen’s ISS website. VisionTracker is an interactive system supporting the overall ISS workflow from outline submission up to project closure. You will be invited to provide all relevant information directly via this website during the whole ISS lifecycle. Access VisionTracker, Ipsen’s ISS website Click here to access Ipsen’s ISS website. If you are a Russian citizen, please contact Ipsen Russia by sending your VisionTracker access request to medical.information.russia.cis@ipsen.com Upon collection of your informed consent on personal data processing, your VisionTracker access will be granted. If you have difficulty with portal access, please email InvestigatorSponsoredStudies@ipsen.com for additional assistance. Tutorials (instructional videos) How to register on VisionTracker Ipsen’s ISS website: How to submit a new ISS proposal: How to submit a project status update and an amendment to active project: For any questions related to the ISS process and/or submissions contact us via InvestigatorSponsoredStudies@ipsen.com Requirements for Ipsen to support your study (ISS) You should have the appropriate scientific and operational capabilities and resources to conduct the study on agreed timelines. You should conduct the study in compliance with laws, rules, regulations and ethical standards (e.g. Declaration of Helsinki, Good Pharmacovigilance Practices, ICH-Good Clinical Practices, Good Pharmaco Epidemiology Practices, Good Laboratory Practices). A mutually agreeable ISS Support Agreement must be executed prior to study initiation. You should provide contractual agreed-upon study status updates. You should monitor and report safety data to the appropriate authorities, in a timely and accurate manner. In addition to reporting safety data to all relevant authorities, you have the responsibility to report the safety information to Ipsen in accordance with the ISS Agreement. You should complete a final study report and/or manuscript in all cases (study completed as per plan or study prematurely terminated). Who may apply ? Health Care Professionals Cooperative Groups Research Institutions Universities or Colleges Requirements to get started Your CV (detailing your qualification, experience in research, training on Good Practices). Outline or Synopsis Form: study title, objectives, hypothesis, study design, study population (inclusion & exclusion criteria) and sample size, study treatment (if any), endpoints and timelines. Study Budget Estimate. STEP 1 ISS Submission You submit a new ISS request via VisionTracker. Ipsen will perform a quality and completeness review. Estimated timelines: STEP 2 ISS Review You submit a detailed synopsis via VisionTracker. Ipsen Medical Affairs Review Board (MARB) perform review and assessment. Estimated timelines: STEP 3 ISS Execution ISS support agreement is signed by all parties. You submit the final study protocol and the regulatory information via VisionTracker. You start the study activities. You provide regular Project Status Updates via VisionTracker. You must report safety findings to Ipsen (adverse.events@ipsen.com). You submit the Final Study Report and/or Manuscript via VisionTracker. A final reconciliation is done via VisionTracker prior to the study close-out. Publishing your ISS Researchers have an ethical duty to publish the clinical research they do. Publishing your scientific research can benefit patients and society as a whole – as well as the wider research community. Click here to know more Our company Our Science Our responsibility Patients Partnering Investors News Center Careers Terms & conditions Data privacy Cookie policy Global Privacy Policy © Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2021 Your privacy is important to us By clicking “Accept All” , you agree to the storing of cookies on your device to enhance site navigation, measure site performance and show you personalized advertising. You can manage individual cookies preferences or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third-parties intervening on our website, please consult the Cookies Policy, available in the site footer. Cookies settings Reject all Accept all